Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Active not recruiting × Carcinoma, Hepatocellular × alectinib × Clear all

Status

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Neoplasms 2 Lung Neoplasms 2 Multiple Endocrine Neoplasia Type 2a 1 Genomic Instability 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1

Interventions

durvalumab 15 Bevacizumab 14 atezolizumab 11 pembrolizumab 9 Magnetic Resonance Spectroscopy 9 Nivolumab 8 lenvatinib 7 tremelimumab 6 Sorafenib 6 camrelizumab 4 Specimen Handling 4 cabozantinib 3 apatinib 3 Radiotherapy 3 Immunoglobulin G 3 E-7386 3 Doxorubicin 3 Disulfides 3 Cyclophosphamide 3 sintilimab 2 budigalimab 2 X-Rays 2 Standard of Care 2 Simvastatin 2 Radiofrequency Ablation 2 Radiation 2 Photons 2 Paclitaxel 2 Immune Checkpoint Inhibitors 2 Hepatectomy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡